Angiotensin II activation of cyclin D1-dependent kinase activity

被引:127
作者
Watanabe, G
Lee, RJ
Albanese, C
Rainey, WE
Batlle, D
Pestell, RG
机构
[1] NORTHWESTERN UNIV, SCH MED, DIV ENDOCRINOL METAB & MOL MED, CHICAGO, IL 60611 USA
[2] NORTHWESTERN UNIV, SCH MED, DEPT MED, DIV NEPHROL & HYPERTENS, CHICAGO, IL 60611 USA
[3] UNIV TEXAS, SW MED CTR, DEPT OBSTET GYNECOL, DALLAS, TX 75235 USA
[4] UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA
关键词
D O I
10.1074/jbc.271.37.22570
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin II (AII) binds to specific G protein-coupled receptors and is mitogenic in adrenal, liver epithelial, and vascular smooth muscle cells. Since the cyclin D1 gene encodes the regulatory subunit of the cyclin D1-dependent kinase (CD1K) required for phosphorylation of the retinoblastoma protein (pRB), an essential and rate-limiting step in G(1) phase progression of the cell cycle, we examined the effect of AII. on cyclin D1 expression and CD1K activity in the human adrenal cell line H295R. AII (10(-6) M) stimulated G(1) phase progression within 12 h, with a maximal effect after 72 h. This action was antedated by the induction of cyclin D1 mRNA (3-fold), cyclin D1 nuclear protein abundance (4-fold), and CD1K activity (4-fold). AT(1) induced cyclin D1 promoter activity 4-fold, via the AT(1) receptor through an enhancer sequence at -954 base pairs. c-Fos and c-Jun bound the cyclin D1 -954 enhancer sequence, and the abundance of c-Fos within this complex was increased by All treatment, AII induced extracellular signal-regulated kinase (ERK) activity 7-fold, and dominant-negative mutants of either p21(ras) or ERK reduced AII stimulated cyclin D1 promoter activity. These findings suggest that AII may stimulate mitogenesis by increasing CD1K activity through a p21(ras)/ERK/activator protein 1 pathway.
引用
收藏
页码:22570 / 22577
页数:8
相关论文
共 73 条
  • [41] DIRECT STIMULATION OF JAK/STAT PATHWAY BY THE ANGIOTENSIN-II AT(1) RECEPTOR
    MARRERO, MB
    SCHIEFFER, B
    PAXTON, WG
    HEERDT, L
    BERK, BC
    DELAFONTAINE, P
    BERNSTEIN, KE
    [J]. NATURE, 1995, 375 (6528) : 247 - 250
  • [42] ELECTROPORATION OF PP60(C-SRC) ANTIBODIES INHIBITS THE ANGIOTENSIN-II ACTIVATION OF PHOSPHOLIPASE C-GAMMA-1 IN RAT AORTIC SMOOTH-MUSCLE CELLS
    MARRERO, MB
    SCHIEFFER, B
    PAXTON, WG
    SCHIEFFER, E
    BERNSTEIN, KE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (26) : 15734 - 15738
  • [43] MARRERO MB, 1994, J BIOL CHEM, V269, P10935
  • [44] SPECIFICITY OF RECEPTOR TYROSINE KINASE SIGNALING - TRANSIENT VERSUS SUSTAINED EXTRACELLULAR SIGNAL-REGULATED KINASE ACTIVATION
    MARSHALL, CJ
    [J]. CELL, 1995, 80 (02) : 179 - 185
  • [45] D-TYPE CYCLIN-DEPENDENT KINASE-ACTIVITY IN MAMMALIAN-CELLS
    MATSUSHIME, H
    QUELLE, DE
    SHURTLEFF, SA
    SHIBUYA, M
    SHERR, CJ
    KATO, JY
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 2066 - 2076
  • [46] COLONY-STIMULATING FACTOR-I REGULATES NOVEL CYCLINS DURING THE G1 PHASE OF THE CELL-CYCLE
    MATSUSHIME, H
    ROUSSEL, MF
    ASHMUN, RA
    SHERR, CJ
    [J]. CELL, 1991, 65 (04) : 701 - 713
  • [47] MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276
  • [48] PRAD-1 CYCLIN-D1 PROTOONCOGENE - GENOMIC ORGANIZATION, 5' DNA-SEQUENCE, AND SEQUENCE OF A TUMOR-SPECIFIC REARRANGEMENT BREAKPOINT
    MOTOKURA, T
    ARNOLD, A
    [J]. GENES CHROMOSOMES & CANCER, 1993, 7 (02) : 89 - 95
  • [49] INDUCTION OF THE PROTOONCOGENE C-JUN BY ANGIOTENSIN-II
    NAFTILAN, AJ
    GILLILAND, GK
    ELDRIDGE, CS
    KRAFT, AS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) : 5536 - 5540
  • [50] MECHANISM OF ANGIOTENSIN-II-INDUCED PROLIFERATION IN BOVINE ADRENOCORTICAL-CELLS
    NATARAJAN, R
    GONZALES, N
    HORNSBY, PJ
    NADLER, J
    [J]. ENDOCRINOLOGY, 1992, 131 (03) : 1174 - 1180